Federal Register Proposed rule: FDA proposes to revise and update the regulations applicable to blood and blood components, including source plasma and source leukocytes, to add donor requirements that are consistent with current practices in the blood industry, and to more closely align the regulations with current FDA recommendations. To view this proposed rule, click here.
